mAbxience
Ayman Ibrahim is the Global Head of Regulatory Affairs & Pharmacovigilance at mAbxience, a biopharmaceutical company specializing in monoclonal antibodies and novel biopharmaceuticals. Prior to mAbxience, Ayman held leadership roles in regulatory affairs at Sandoz and Pharmascience. With a background in Cell and Molecular Biology, Ayman has a proven track record of successfully leading regulatory strategies and submissions for various markets worldwide. Ayman also holds an Executive MBA from Kellogg-WHU and has demonstrated expertise in global regulatory governance and market entry strategies.